CytomX Therapeutics (CTMX) Goodwill & Intangibles (2014 - 2026)
CytomX Therapeutics (CTMX) reported Goodwill & Intangibles of $1.31 million for Q2 2026, down 9.9% from $1.46 million a year earlier and down 2.7% from the prior quarter.
Powered by 
Analysis
CytomX Therapeutics (CTMX) Goodwill & Intangibles (2014 - 2026) Analysis & Trends
At the end of FY2025, CytomX Therapeutics posted Goodwill & Intangibles of $1.39 million, down 9.5% from FY2024.
- Goodwill & Intangibles has declined for nine consecutive years, with a five-year compound annual growth rate of -8.1% (FY2020 to FY2025).
- By year, Goodwill & Intangibles came in at $1.53 million in FY2024 (-8.7%), $1.68 million in FY2023 (-8.0%), $1.82 million in FY2022 (-7.4%) and $1.97 million in FY2021 (-6.9%).
- The Q2 2026 figure ranks as the lowest quarterly Goodwill & Intangibles in data going back to Q4 2014.
- Year over year, Goodwill & Intangibles has now declined in each of the last 36 quarters, with an average decline of 9.2% over the last eight quarters.
- Over the past five years, the year-over-year decline in Goodwill & Intangibles ranged from 6.8% (Q3 2021) to 9.9% (Q2 2026).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.35 million (Q1 2026), $1.39 million (Q4 2025) and $1.42 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | CytomX Therapeutics | 573.08 Mn | -384.59 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.31 Mn |
| Mar 31, 2026 | 1.35 Mn |
| Dec 31, 2025 | 1.39 Mn |
| Sep 30, 2025 | 1.42 Mn |
| Jun 30, 2025 | 1.46 Mn |
| Mar 31, 2025 | 1.50 Mn |
| Dec 31, 2024 | 1.53 Mn |
| Sep 30, 2024 | 1.57 Mn |
| Jun 30, 2024 | 1.61 Mn |
| Mar 31, 2024 | 1.64 Mn |
| Dec 31, 2023 | 1.68 Mn |
| Sep 30, 2023 | 1.72 Mn |
| Jun 30, 2023 | 1.75 Mn |
| Mar 31, 2023 | 1.79 Mn |
| Dec 31, 2022 | 1.82 Mn |
| Sep 30, 2022 | 1.86 Mn |
| Jun 30, 2022 | 1.90 Mn |
| Mar 31, 2022 | 1.93 Mn |
| Dec 31, 2021 | 1.97 Mn |
| Sep 30, 2021 | 2.01 Mn |
API Access
CytomX Therapeutics Goodwill & Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=goodwill-and-intangibles&ticker=CTMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "goodwill-and-intangibles", "ticker": "CTMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=goodwill-and-intangibles&ticker=CTMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();